Flow Cytometry Services Market Envisions USD 8.39 Billion By 2034, Growing At A 9.77% CAGR
Ottawa, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The global flow cytometry services market
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @Key Takeaways
- North America held a major revenue share of the market in 2024. Asia Pacific is expected to witness the fastest growth in the flow cytometry services market during the forecast period. By accreditation type, the government segment held a major revenue share of the market in 2024. By accreditation type, the third-party accreditation segment is expected to witness significant growth in the market during the forecast period. By service type, the analysis segment held a major revenue share of the market in 2024. By service type, the general flow segment is expected to witness significant growth in the market during the forecast period.
What are the Flow Cytometry Services?
The flow cytometry services market is driven by increasing diseases, biopharmaceutical investments cell sorting stem cell researchWhat are the Major Drivers in the Flow Cytometry Services Market?
Expanding clinical research is the major driver in the market. This, in turn, is increasing the demand for flow cytometry services in immunology, stem cells, oncology research growth in personalized medicine cell-based therapies You can place an order or ask any questions, please feel free to contact us at ...What are the Key Drifts in the Flow Cytometry Services Market?
The market has been expanding due to the growing collaborations and acquisitions, to launch and enhance the use of various flow cytometry services.
- In October 2025, a two-part research support initiative to enhance the accessibility of cell analysis, a collaboration between Cytek Biosciences and the International Society for Advancement of Cytometry, focusing on the adoption of cytometry technology, was announced. In June 2025, the successful acquisition of Cellular Highways Ltd, which is a biotechnology company with advanced cell sorting technologies and applications in cell and gene therapy, general cell research, and drug discovery, was announced by STEMCELL Technologies. In April 2025, a collaboration between 1Cell and BioSkryb Genomics was announced to develop and launch next-generation single-cell multi-omic solutions for the detection and characterization of rare mutations in single cells.
What is the Significant Challenge in the Flow Cytometry Services Market?
High cost acts as the major challenge in the market. The continuous use of reagents, instrument maintenance, and operational costs all limit the adoption of these services across smaller labs and limited infrastructure regions. Moreover, the growing operational complexities, shortage of skilled professionals, competition from alternative technologies, and regulatory challenges are other market restraints.
Regional Analysis
How did North America Dominate the Flow Cytometry Services Market in 2024?
In 2024, North America captured the biggest revenue share in the market, due to the presence of robust research infrastructure, which increases the use of these services in the research institutes, industries, and universities. They were also used for diagnostic applications and the development of personalized medicine by hospitals and industries. Moreover, the industries are developing advanced flow cytometry systems, which were backed by funding and investments, and also contributed to the market growth.
The U.S. Flow Cytometry Services Market Trends:
Due to the presence of strong healthcare infrastructure, the use of flow cytometry services in the U.S. is increasing. At the same time, the high healthcare spending and funding are driving their adoption across the pharmaceutical
Become a valued research partner with us -The Canada Flow Cytometry Services Market Trends:
The expanding industries in Canada are increasing the use of flow cytometry services for R&D purposes. They are also being used in various labs for diagnostic applications. At the same time, the growing government initiatives and investments from various sources are being used to support their use in advanced cell technologies and life science researchWhat Made Asia Pacific Grow Notably in the Flow Cytometry Services Market in 2024?
Asia Pacific is expected to host the fastest-growing cannabidiol market during the forecast period, due to growing R&D activities. At the same time, the growing incidence of cancer, infectious diseases, and immune-related diseases is increasing the use of these services for diagnostic purposes. The growing innovations, healthcare investments, and technological advancements are also increasing their use. Additionally, the growing collaborations and government support are promoting the market growth.
The China Flow Cytometry Services Market Trends:
The presence of advanced industries in China is increasing the use of flow cytometry services for R&D and diagnostic applications. They are also being used in the development of precision medicines
The India Flow Cytometry Services Market Trends:
The growing advancements in research and development across various industries are increasing the demand for flow cytometry services. Additionally, the expanding infrastructure is driving the adoption of diagnostic tools, which is encouraging the use of these services. Furthermore, the government initiatives are supporting their use to accelerate the clinical trials Get the latest insights on life science industry segmentation with our Annual Membership:Segmental Insights
By accreditation analysis
Which Accreditation Type Segment Held the Dominating Share of the Flow Cytometry Services Market in 2024?
By accreditation type, the government segment held the dominating share of the market in 2024, due to its strict quality and safety standards. At the same time, they offered uniform protocols for labs, which helped in reducing the data variability. Moreover, they ensured consistent public health monitoring, where these factors promoted the use of flow cytometry services.
By accreditation type, the third-party accreditation segment is expected to show lucrative growth in the market during the predicted time, due to its rapid certification process. They also offer internationally recognized certifications, which encourage global collaborations. Additionally, they can customize the standards depending on the applications, such as cell therapy, single-cell analysisBy service analysis
What Made Analysis the Dominant Segment in the Flow Cytometry Services Market in 2024?
By service type, the analysis segment led the market in 2024, as it is important for the detection of cell populations, immune responses, and biomarkers. They were also required for the interpretation of the multidimensional datasets generated. This, in turn, increased the adoption of various analytical software and tools for diagnostic purposes and data analysis.
By service type, the general flow segment is expected to show notable growth in the market during the upcoming years, due to its wide range of research, clinical testing, and diagnostic applications. They also offer more accessible and affordable flow cytometry services. Additionally, the growing routine testing demand is also increasing their use.
Recent Developments in the Flow Cytometry Services Market
- In April 2025, for high-resolution, single-cell profiling and cytokine analysis, a next-generation Cytometry by Time-Of-Flight (CyTOF) Inflammatory Response Assay was launched by Aliri Bioanalysis. In April 2025, the Beacon DiscoveryTM Optofluidic System, providing an accessible entry point into live single-cell functional analysis, was launched by Bruker Corporation.
Browse More Insights of Towards Healthcare:
The global small molecule API market size
The global infant nutrition market size
The global cell-based assays market size
The strand displacement amplification (SDA) market
The global biologics contract research organization market
The global liquid biopsy market
The global artificial intelligence in life sciences market
The global biopharmaceuticals market
The global antibodies drug market
The global ambulatory healthcare services market
Flow Cytometry Services Market Key Players List
- Q2 Solutions Bio-Legend Flow Contract Sites Laboratory FlowMetric Life Sciences MLM Medical Labs ProImmune Firalis Unilabs Life Science Research ACROBIOsystems Ardena Agilex Biolabs CHOP Research Institute Cell flow cytometry Research Lab Services Fluorescence Proimmune Aurelia Bioscience Plant Cytometry services Bio-Rad Laboratories FACS Services Beckman Coulter Sphere Fluidics Limited IBR Inc. Icon plc Rockland-inc NeoGenomics ACM Global Laboratories Charles River Laboratories ReachBio RayBiotech Mdbiosciences CSI Laboratories ProMab Creative Proteomics Covance
Segments Covered in The Report
By Accreditation Type
- Government Third-Party Accreditation
By Service Type
- General Flow Cytometric Service
- Assay Development Consumables Manufacturing
- PBMC Analysis Whole Blood Cells Analysis Bone Marrow Aspirate Analysis Stem Cells Analysis Rare Cells Detection Cell Profiling and subset Intracellular staining
By Region
North America
- U.S. Canada Mexico Rest of North America
South America
- Brazil Argentina Rest of South America
Europe
- Western Europe
- Germany Italy France Netherlands Spain Portugal Belgium Ireland UK Iceland Switzerland Poland Rest of Western Europe
- Austria Russia & Belarus Türkiye Albania Rest of Eastern Europe
Asia Pacific
- China Taiwan India Japan Australia and New Zealand, ASEAN Countries (Singapore, Malaysia) South Korea Rest of APAC
MEA
- GCC Countries Saudi Arabia United Arab Emirates (UAE) Qatar Kuwait Oman Bahrain South Africa Egypt Rest of MEA
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard:About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research You can place an order or ask any questions, please feel free to contact us at ...Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web:Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment